Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro

Drugs under Experimental and Clinical Research

Volumn 23, Issue 3-4, 1997, Pages 97-102

  Wang, Y Z ^a   Liu, X Y ^a   Wu, L J ^a   Zhang, Y B ^a   Hou, L ^a   Xu, Q S ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; LEUKEMIA, EXPERIMENTAL; MICE; PHOSPHORYLCHOLINE; TUMOR CELLS, CULTURED;

EID: 0031350650     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hilgard P., Klenner T., Stekar J., Unger C. Alkylphosphocholines: a new class of membrane active anticancer agents. Cancer Chemother. Pharmacol., 32, 90-95, 1993.
2. Stekar J. et al. A novel alkylphospholipid with arsenic substituting for nitrogen (D-21805). J. Cancer Res. Clin. Oncol., 120 (Suppl.) R164, 1994.
3. Vogler W.R. Bone marrow purging in acute leukemia with alkyllysophospholipids: a new family of anticancer drugs. Leukemia & Lymphoma, 13, 53-60, 1994.
4. Kaufman-kolle P. et al. Liposomal hexadecylphosphocholine: characterization and effects on adherent tumor cells. J. Liposome Research, 4, 1115-1134, 1994.
5. Zeisig R., Jungmann S., Fichtner I., Daemen T., Arndt D. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine liposomes and macrophages on tumor cells. Anticancer Res., 14, 1785-1790, 1994.
6. Berkovin D., Berkvin K., Fleer E.A.M., Eibl H., Unger C. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-0-octadecyl-2-0-methyl-rac-glycero-3-phosphocholine does not correlate with inhibition of proliferation of HL60 and K562 cell lines. Eur. J. Cancer 30A, 509-515, 1994.
7. 2+ concentration in a normal and a breast cancer cell line. Anticancer Res., 14, 1594-1556, 1994.
8. Marl M. et al. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anti-Cancer Drug Design, 10, 411-425, 1995.
9. Bruckheimer E.M., Schroit A.J. Membrane phospholipid asymmetry: host response to the externalization of phosphatidylserine. J. Leukoc. Biol., 59, 784-789, 1996.
10. Arndt D., Zeisig R., Eue I., Fichtner I. Alkylphosphocholines and alkylphosphocholines liposomes. J. Liposome Res., 1, 91-98, 1995.